Emcure Pharmaceuticals IPO targets ₹1,952 crore.

Strategic financial leapEmcure Pharmaceuticals, a leading Pune-based pharmaceutical business, aims to raise ₹1,952 crore through an IPO. The IPO will open for subscription on July 3, 2024, offering 7.9 million equity shares worth ₹800 crore and an OFS of 11.4 million shares worth ₹1,152.03 crore. IPO Details and PriceThe IPO’s price range is ₹960 to…

Read More

CDSL Soars 13% to Record High Amid Bonus Issue Talks

In intraday trading on Friday, shares of Central Depository Services (India) Limited (CDSL) surged 13% to a record high of Rs 2,260 on the National Stock Exchange (NSE). This increase came after the business declared that on July 2, 2024, its board will review a first bonus issuance. The share price increased over its June…

Read More